Chemylix draws together scientists and executives driven by a common purpose:
to bring novel medicines to market and to patients by exploring a new frontier in chemistry.
Today, the demanding business of inventing truly novel
medicines is being compounded by a renewed scrutiny over their
safety profile. In this context, Chemylix executes on
a paradigm-shifting strategy: we provide our customers with
the right chemistry, right from the start.
We emphasize
biological relevance over throughput; we put a premium on
structural diversity rather than on quantity; we unyieldingly challenge stereotypic mindsets biased by dogma and habits to deliver
genuinely innovative chemistry.
We leverage
our distinctive, hybrid technology to deliver
a superior product that skillfully obviates the many pitfalls mining the development path to safe, effective and profitable drugs.
To our customers, we provide
points of entry into
pristine and proprietary molecular fields within the biosphere
envelope, where unrestricted structural roaming ensures effective therapeutic index optimization.
We operate as
an engine of innovation for the pharmaceutical industry. This is where the heart of the opportunity lies. This is
Chemistry for Lives.
The Chemylix team.
